Cargando…
Effect Modification by Social Determinants of Pharmacogenetic Medication Interactions on 90-Day Hospital Readmissions within an Integrated U.S. Healthcare System
The present study builds on our prior work that demonstrated an association between pharmacogenetic interactions and 90-day readmission. In a substantially larger, more diverse study population of 19,999 adults tracked from 2010 through 2020 who underwent testing with a 13-gene pharmacogenetic panel...
Autores principales: | Saulsberry, Loren, Singh, Lavisha, Pruitt, Jaclyn, Ward, Christopher, Wake, Dyson T., Gibbons, Robert D., Meltzer, David O., O’Donnell, Peter H., Cruz-Knight, Wanda, Hulick, Peter J., Dunnenberger, Henry M., David, Sean P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319564/ https://www.ncbi.nlm.nih.gov/pubmed/35887642 http://dx.doi.org/10.3390/jpm12071145 |
Ejemplares similares
-
The Contribution of Pharmacogenetic Drug Interactions to 90-Day Hospital Readmissions: Preliminary Results from a Real-World Healthcare System
por: David, Sean P., et al.
Publicado: (2021) -
Underrepresented patient views and perceptions of personalized medication treatment through pharmacogenomics
por: Saulsberry, Loren, et al.
Publicado: (2021) -
Factors Associated With Extended Length of Stay and 90-Day Readmission Rates
Following ACDF
por: Dial, Brian L., et al.
Publicado: (2019) -
Pharmacogenomic Clinical Decision Support: A Review, How‐to Guide, and Future Vision
por: Wake, Dyson T., et al.
Publicado: (2021) -
Variant Interpretation in Current Pharmacogenetic Testing
por: Luvsantseren, Sally, et al.
Publicado: (2020)